Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Unilife Receives SPP Applications Exceeding A$12.8 Million

December 31, 2010 By Bio-Medicine.Org

LEWISBERRY, Pa., Dec. 31, 2010 /PRNewswire/ — Unilife
Corporation (Unilife or Company) (Nasdaq:
UNIS
; ASX: UNS) announced today that its 2010 Share Purchase
Plan (SPP), which closed on Wednesday, 22 December 2010, was
significantly oversubscribed. The Company has received applications
for approximately 15.1 million new CHESS Depositary Interests
(CDIs) at an issue price of A$0.85 (each CDI representing an
interest in one sixth of a share of the Company’s common stock)
with a value of approximately A$12.8 million.

As announced on 7 December 2010, Unilife offered eligible
shareholders with a registered address in Australia or New Zealand
the opportunity to subscribe for up to A$15,000 worth of CDIs under
the SPP. As a result of the overwhelming demand for CDIs under the
SPP, and to ensure all shareholders that applied under the SPP have
the ability to participate, the Unilife Board has subsequently
authorised an increase in the number of CDIs to be issued under the
SPP.

Initially, up to 8,235,294 CDIs were to be issued to raise up to
A$7 million as disclosed in the Company’s 2010 SPP documentation.
Due to strong demand amongst eligible shareholders, 15,058,920 CDIs
will now be issued to raise approximately A$12.8 million before
costs.  

Unilife intends to use the proceeds raised from the SPP for the
purchase of additional capital equipment, for general operations
including moving forward with the development of additional
pipeline products and supporting the 2011 transition of Unilife
into a commercial manufacturer and supplier of its proprietary
medical devices to pharmaceutical and healthcare companies.

Comment from Unilife Chief Executive Officer, Mr Alan
Shortall
“The Board and I are very pleased by the
overwhelming support displayed by eligible shareholders applying
for CDIs in the SPP. We received applic

‘/>”/>

SOURCE

Related Articles Read More >

The most innovative medical devices of 2026
An illustration showing Corcym's Memo 4D Curve's laser-cut nitinol core.
Laser-cut nitinol and a layered design let these cardiac implants flex
Reconstructed 3D fluorescence image of the stained biohybrid mesh-tissue integration. The red, green, and blue colors correspond to the mesh, F-actin, and nuclei, respectively.
Researchers mesh electronics with human cells to develop living battery
A photo of the Paradromics Connexus brain-computer interface on a fingertip.
How Paradromics designed its Connexus brain-computer interface system
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2026 Arrowfly, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2026
    • The 2026 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Educational Assets
    • Manufacturer Search
    • Podcasts
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Views
    • Video
  • 2026 Leadership
    • 2025 Winners
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe